Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Neonc Technologies, Inc.
Children's Oncology Group
C17 Council
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
Hoosier Cancer Research Network
Masonic Cancer Center, University of Minnesota
Latin American Cooperative Oncology Group
Beijing Sanbo Brain Hospital
St. Anna Kinderkrebsforschung